BRIEF-Axsome Therapeutics Q4 Net Income USD -28.559 Million

Axsome Therapeutics, Inc. -1.18%

Axsome Therapeutics, Inc.

AXSM

182.01

-1.18%

Feb 23 (Reuters) - Axsome Therapeutics Q4 operating expenses USD 222.956 million.

  • Q4 operating income USD -26.957 million
  • Q4 pretax profit USD -28.129 million